Search research articles
Contact Us
Filters
Showing results (1-10 of 135) with videos related to
Page
of 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 18, 2008
Use of pharmacokinetics and pharmacodynamics in a failure analysis of community-acquired pneumonia: implications for future clinical trial study design
Paul G Ambrose
Nature Medicine
|
July 9, 2011
Antibiotic bill doesn't GAIN enough ground
Paul G Ambrose
Treatments in Respiratory Medicine
|
April 23, 2005
Antimicrobial susceptibility breakpoints: PK-PD and susceptibility breakpoints
Paul G Ambrose
Current Opinion in Pharmacology
|
July 9, 2017
Antibacterial drug development program successes and failures: a pharmacometric explanation
Paul G Ambrose
Managed Care Interface
|
May 14, 2005
Framing the threat of resistance to quinolones in pharmacologic terms
Paul G Ambrose
Pharmacotherapy
|
March 2, 2006
Monte Carlo simulation in the evaluation of susceptibility breakpoints: predicting the future: insights from the society of infectious diseases pharmacists
Paul G Ambrose
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 18, 2006
Extended-spectrum beta-lactamases and clinical outcomes: current data
Reuben Ramphal, Paul G Ambrose
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 9, 2005
Antimicrobial safety: focus on fluoroquinolones
Robert C Owens, Paul G Ambrose
Pharmacotherapy
|
May 16, 2002
Torsades de pointes associated with fluoroquinolones
Robert C Owens, Paul G Ambrose
Diagnostic Microbiology and Infectious Disease
|
February 13, 2007
Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era
Robert C Owens, Paul G Ambrose
Page
of 14
Search research articles
Search
Showing results (1-10 of 135) with videos related to
Sort By:
Page
of 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 18, 2008
Use of pharmacokinetics and pharmacodynamics in a failure analysis of community-acquired pneumonia: implications for future clinical trial study design
Paul G Ambrose
Nature Medicine
|
July 9, 2011
Antibiotic bill doesn't GAIN enough ground
Paul G Ambrose
Treatments in Respiratory Medicine
|
April 23, 2005
Antimicrobial susceptibility breakpoints: PK-PD and susceptibility breakpoints
Paul G Ambrose
Current Opinion in Pharmacology
|
July 9, 2017
Antibacterial drug development program successes and failures: a pharmacometric explanation
Paul G Ambrose
Managed Care Interface
|
May 14, 2005
Framing the threat of resistance to quinolones in pharmacologic terms
Paul G Ambrose
Pharmacotherapy
|
March 2, 2006
Monte Carlo simulation in the evaluation of susceptibility breakpoints: predicting the future: insights from the society of infectious diseases pharmacists
Paul G Ambrose
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 18, 2006
Extended-spectrum beta-lactamases and clinical outcomes: current data
Reuben Ramphal, Paul G Ambrose
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 9, 2005
Antimicrobial safety: focus on fluoroquinolones
Robert C Owens, Paul G Ambrose
Pharmacotherapy
|
May 16, 2002
Torsades de pointes associated with fluoroquinolones
Robert C Owens, Paul G Ambrose
Diagnostic Microbiology and Infectious Disease
|
February 13, 2007
Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era
Robert C Owens, Paul G Ambrose
Page
of 14